This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone Q2 FY2026-27 revenue falls to Rs277.79 lakh from Rs869.23 lakh a year earlier
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts less than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone Q2 FY2026-27 revenue: Rs277.79 lakh versus Rs869.23 lakh a year earlier; PAT: Rs27.15 lakh versus Rs12.65 lakh. Standalone half-year revenue: Rs614.02 lakh versus Rs1,336.93 lakh; PAT: Rs39.20 lakh versus Rs6.60 lakh. Margin before other income, interest, tax and depreciation fell from 4.7% to negative 11.5%. Half-year operating cash flow: negative Rs399.33 lakh. Q1 related-party factory sale: Rs392.75 lakh; registration pending.
Weaker sales and cash flow may pressure the stock despite higher profit; the related-party factory sale adds risk.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹2.78 Cr | ₹8.69 Cr | −68.0% |
| Operating profit | −₹0.36 Cr | −₹0.01 Cr | loss widened |
| Profit after tax | ₹0.27 Cr | ₹0.12 Cr | +135.7% |
| EBITDA margin | -11.5% | 4.6% | −16.1 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.